KHKristine Ria Hearld

Kristine Ria Hearld

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kristine Ria Hearld has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Association of Hospitals' Organizational Characteristics and Market Factors Offering Integrative Medicine Services to Adult Patients With Cancer

    by Sanober Ajani, Kristine Ria Hearld, Soumya J. Niranjan, Allyson Hall, Gabriel Lopez, Nancy Borkowski

    PURPOSE: Demand for integrative medicine (IM) in cancer care is increasing, yet limited data exist regarding which hospitals offer IM services and what those services include. This exploratory cross-sectional study aimed to (1) examine organizational characteristics and market factors of cancer hospitals that offered IM services and those that did not; and (2) identify the types of services included in IM programs within cancer hospitals and their funding sources. METHODS: Bivariate analysis evaluated the relationship between the dependent variable (cancer hospitals offering IM services) and the independent categorical variables. χ 2 tests were performed for categorical variables, and t tests were used to compare means for continuous variables. An electronic survey was developed and distributed to 150 IM program leaders. The survey assessed service offerings, delivery settings, referrals, funding, barriers, and facilitators. Descriptive statistics were used to summarize and describe survey results. Results: Key findings showed statistically significant associations between cancer hospitals providing IM services and those that did not. A higher proportion of cancer hospitals with IM programs offered palliative care services, were not-for-profit, larger (bed size 400+), teaching entities located in metropolitan areas with larger populations and higher per capita income. Most frequently offered IM services were nutrition counseling, acupuncture, and massage therapy. Additionally, philanthropy was essential in providing financial support for IM services. CONCLUSION: This study emphasizes the need for a better understanding of the factors influencing the availability and accessibility of IM services in cancer care. IM programs are increasingly embedded within cancer centers, offering diverse services to support patients' symptom management and quality of life. However, funding, staffing, and integration variations reflect a need for standardized models and best practices.


  • Open Access

    A Technology-Enhanced Medical Nutrition Therapy and Diabetes Self-Management Education for Adults With Disability and Type 2 Diabetes: Protocol for a Pilot and Feasibility Randomized Controlled Trial

    by Anita Aboagye, Jessica Peckham, Kristine Ria Hearld, Shireen Abdullah, Mohanraj Thirumalai

    Background: Diabetes mellitus (DM) is a serious chronic disorder that affects many individuals globally, particularly persons with disabilities, and has long-term adverse effects on the health of individuals and society. Effective self-management education is therefore required. Diabetes management focused on medical nutrition therapy (MNT) and diabetes self-management education (DSME) combined with telehealth technology has the potential to increase the active performance of diabetes management behaviors among persons with disabilities and improve their overall quality of life and quality of self-care. Objective: This study aims to evaluate the impact of different levels of technology on the delivery of MNT and DSME among persons with disabilities. Methods: The study is a single-blinded, 3-arm, randomized controlled trial among adults living with both type 2 diabetes and a permanent physical disability. Web-based recruitment is done through partner organizations. The target sample size is 90 participants randomized into 3 arms: a high-technology, a low-technology, and an attention control arm. The high-technology arm receives diabetes-related materials weekly through mediums such as email, a telehealth platform, and text; the low-technology arm receives only 1 weekly email with diabetes-related material; and the attention control arm has no technology support. The intervention is provided by a certified diabetes care and education specialist. Using multivariate linear mixed models, the study examines the relationships between the level of technology intervention and DM self-management behaviors, self-efficacy, and reductions in glycated hemoglobin (HbA1c). The primary outcome is the proportion of participants in each group with improved self-management behaviors, as measured by several validated questionnaires. The secondary outcome is a better HbA1c reduction. Outcomes are measured at baseline and at 6 months. Questionnaires and HbA1c measures will be used to measure outcomes. Results: Data collection began in June 2024 with a total of 90 recruited participants. The intervention was delivered. Make-up classes were delivered to participants in any of the 3 cohorts between November 2024 and December 2024. The final 3-month follow-up classes were held for each cohort 3 months after the first class. Data analysis is anticipated to be completed in fall 2025. Conclusions: Effective self-management in DM is important to reduce complications. Using technology to deliver MNT and DSME could serve as an effective and convenient strategy for providing these interventions. However, intervention studies are required to determine the most effective level of technology for delivering MNT and DSME intervention to this target group. The YumABLE study is expected to provide new, meaningful, and detailed information about the effectiveness of technology and telehealth platforms for effectively delivering an MNT and DSME program for people living with a permanent physical disability and type 2 diabetes. The results will further improve web- and technology-based diabetes self-management interventions for people with disabilities. Trial Registration: ClinicalTrials.gov NCT06049225; https://clinicaltrials.gov/study/NCT06049225 International Registered Report Identifier (IRRID): DERR1-10.2196/71495

  • Open Access

    A Technology-Enhanced Medical Nutrition Therapy and Diabetes Self-Management Education for Adults With Disability and Type 2 Diabetes: Protocol for a Pilot and Feasibility Randomized Controlled Trial (Preprint)

    by Anita Aboagye, Jessica Peckham, Kristine Ria Hearld, Shireen Abdullah, Mohanraj Thirumalai

    BACKGROUND Diabetes mellitus (DM) is a serious chronic disorder that affects many individuals globally, particularly persons with disabilities, and has long-term adverse effects on the health of individuals and society. Effective self-management education is therefore required. Diabetes management focused on medical nutrition therapy (MNT) and diabetes self-management education (DSME) combined with telehealth technology has the potential to increase the active performance of diabetes management behaviors among persons with disabilities and improve their overall quality of life and quality of self-care. OBJECTIVE This study aims to evaluate the impact of different levels of technology on the delivery of MNT and DSME among persons with disabilities. METHODS The study is a single-blinded, 3-arm, randomized controlled trial among adults living with both type 2 diabetes and a permanent physical disability. Web-based recruitment is done through partner organizations. The target sample size is 90 participants randomized into 3 arms: a high-technology, a low-technology, and an attention control arm. The high-technology arm receives diabetes-related materials weekly through mediums such as email, a telehealth platform, and text; the low-technology arm receives only 1 weekly email with diabetes-related material; and the attention control arm has no technology support. The intervention is provided by a certified diabetes care and education specialist. Using multivariate linear mixed models, the study examines the relationships between the level of technology intervention and DM self-management behaviors, self-efficacy, and reductions in glycated hemoglobin (HbA1c). The primary outcome is the proportion of participants in each group with improved self-management behaviors, as measured by several validated questionnaires. The secondary outcome is a better HbA1c reduction. Outcomes are measured at baseline and at 6 months. Questionnaires and HbA1c measures will be used to measure outcomes. RESULTS Data collection began in June 2024 with a total of 90 recruited participants. The intervention was delivered. Make-up classes were delivered to participants in any of the 3 cohorts between November 2024 and December 2024. The final 3-month follow-up classes were held for each cohort 3 months after the first class. Data analysis is anticipated to be completed in fall 2025. CONCLUSIONS Effective self-management in DM is important to reduce complications. Using technology to deliver MNT and DSME could serve as an effective and convenient strategy for providing these interventions. However, intervention studies are required to determine the most effective level of technology for delivering MNT and DSME intervention to this target group. The YumABLE study is expected to provide new, meaningful, and detailed information about the effectiveness of technology and telehealth platforms for effectively delivering an MNT and DSME program for people living with a permanent physical disability and type 2 diabetes. The results will further improve web- and technology-based diabetes self-management interventions for people with disabilities. CLINICALTRIAL ClinicalTrials.gov NCT06049225; https://clinicaltrials.gov/study/NCT06049225 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/71495

  • The Relationship Between Leadership Characteristics and Services Provided Among IHS Urban Indian Health Programs

    by G. Grant Dsc Tribble, Nancy M. Borkowski, Phaedra S. Corso, Allyson G. Hall, Kristine R. Hearld

    The Urban Indian Health Program was created by the Indian Health Service to establish a culturally appropriate health care delivery model for Native Americans who relocate to urban areas. The 31 community-based Indian Health Programs under the Office of Urban Indian Health Program vary in culture, socioeconomic, and patient mix. Strategic decision-making by these community-based Indian Health Programs depends upon various factors, including leaders’ characteristics, organizational characteristics, and service area market factors.

  • The role of patient and family advisory boards in promoting greater attention to patient social needs by U.S. acute care hospitals

    by Larry R. Hearld, J’aIme Jennings, Demetria Hubbard, Seung-Yup Lee, Kristine R. Hearld

    Background: There is growing attention to individual-level patient social needs such as unstable housing and food insecurity. Such considerations, however, have historically been the purview of public health and have not been a priority of more traditional health care delivery organizations, such as acute care hospitals. Purpose: The purpose of this study was to examine whether the presence of patient and family advisory boards (PFABs) among acute care community hospitals was associated with screening for and programs to address patient social needs. Methods: We used a secondary data set derived from the American Hospital Association’s 2020 and 2021 annual surveys, along with multinomial and negative binomial regression models to assess the relationship between the presence/absence of a PFAB and the likelihood of offering and the number of areas addressed by social needs screening programs. Results: More than half (55.9%) of all responding hospitals reported having a PFAB in 2020 (55.9%) and 2021 (52.7%). The presence of a PFAB among hospitals was significantly associated with patient social needs screening, more areas addressed by programs, and more types of partners to address these needs. Conclusions: Community hospitals with a PFAB have more robust programs and partnerships to address patient social needs. Practice Implications: Hospital leaders should consider going beyond simply establishing programs to address social needs but also consider comprehensiveness of these programs to recognize the intersectionality of social needs. One way to do this is to formally establish a PFAB to help hospitals better identify and prioritize the needs in local communities and design social needs programs/solutions that are patient- and family-centric.


  • Improving Communication with Family Members during a Global Pandemic: Effect on Patient Experience

    by Gregory N. Orewa, Sue S. Feldman, Kierstin Cates Kennedy, Allyson G. Hall, Yu H. Cheng, Arnaz A. Malone, Ernest O. Grimes, Kristine Ria Hearld, Ph D, Mba, et al.

    Objectives: Communication with patients and their families/caregivers to facilitate informed decision making is an integral part of patient/family-centered care. Due to the high coronavirus disease 2019 (COVID-19) infection rates and limited personal protective equipment, healthcare systems were forced to restrict patient visitors, limit patient–provider interactions, and implement other...


  • Open Access

    The Relationship between Leadership, Organizational and Market Characteristics and Services Provided among IHS Urban Indian Health Programs

    by Grant Tribble, Nancy Borkowski, Phaedra Corso, Allyson Hall, Kristine R. Hearld

    The Urban Indian Health Program (UIHP) was created by the Indian Health Service to establish a culturally appropriate health care delivery model for Native Americans who relocate into urban areas. For each of the 31 UIHP facilities, the geography, socioeconomic characteristics, and culture of the patient mix is varied, and the leaders of each facility affect the strategic direction and planning of the health care services offered and the adaptation of the health care services offerings to each of its populations. The purpose of this exploratory study was to determine if, within the UIHP, there is a relationship among the characteristics of the leaders and the leader’s strategic decisions relating to services provided. We found that the planning and execution of the UIHP’s strategy depends upon a variety of factors including the leaders’ individual characteristics, the organizational characteristics of each program, and the market factors of each service area.

  • Open Access

    Economic Evaluation of Anesthesiology-Led Cardiac Implantable Electronic Device Service

    by Ahmed Zaky, Ryan L. Melvin, David Benz, James Davies, Vardas Panayotis, William Maddox, Ruchit Shah, Tom Lynch, Adam Beck, Kristine Hearld, et al.

    Background: Implementation of an anesthesiology-led cardiac implantable electronic device (CIED) service can be viewed to have economic and efficiency challenges. This study evaluates the cost savings of an anesthesiology-led CIED service. Methods: A total of 830 patients presented in the pre-implementation period from 1 March 2016 to 31 December 2017, and 1981 patients presented in the post-implementation period from 1 January 2018 to 31 October 2021. Interrupted time-series analysis for single-group comparisons was used to evaluate the cost savings resulting from reduction in operating room (OR) start delays for patients with CIEDs. Results: OR start-time delay was reduced by 10.6 min (95%CI: −20.5 to −0.83), comparing pre- to post-implementation. For an OR cost of USD 45/min, we estimated the direct cost to the department to be USD 1.68/min. The intervention translated into a total cost reduction during the intervention period of USD 250,000 (USD 18,000 to USD 470,000) per year for the institution and USD 9800 (USD 730 to USD 17,000) per year for the department. The yearly cost of employing a full-time team of CIED specialists would have been USD 135,456. The service triggered electrophysiology consultation on 13 device malfunctions. Conclusions: An anesthesiology-led CIED service resulted in substantial cost savings, increased OR efficiency and patient safety.


  • Open Access

    Clinical Outcomes in COVID-19 Patients Treated with Immunotherapy

    by Haris Hatic, Kristine R. Hearld, Devika Das, Jessy Deshane

    Introduction: The full impact of COVID-19 infections on patients with cancer who are actively being treated with chemotherapy or immune checkpoint inhibitors (ICIs) has not been fully defined. Our goal was to track clinical outcomes in this specific patient population. Methods: We performed a retrospective chart review of 121 patients (age > 18 years) at the University of Alabama at Birmingham from January 2020 to December 2021 with an advanced solid malignancy that were eligible to be treated with ICIs or on current therapy within 12 months of their COVID-19 diagnosis. Results: A total of 121 patients were examined in this study, and 61 (50.4%) received immunotherapy treatment within 12 months. One quarter of the patients on ICIs passed away, compared to 13% of the post-chemotherapy cohort. Patients who were vaccinated for COVID-19 had lower mortality compared to unvaccinated patients (X2 = 15.19, p < 0.001), and patients with lower ECOG (0.98) were associated with lower mortality compared to patients with worse functional status (0.98 vs. 1.52; t = 3.20; p < 0.01). Conclusions: COVID-19-related ICI mortality was higher compared to patients receiving chemotherapy. However, ICI cessation or delay is unwarranted as long there has been a risk–benefit assessment undertaken with the patient.


  • A Geographically Contextualized Examination of LGBT Inclusive Healthcare Organizations in the U.S.

    by Seongwon Choi, Kristine Ria Hearld, Nancy Borkowski

    Over the last twenty years, the United States has experienced significant changes in public opinion in support for LGBTQ (lesbian, gay, bisexual, transgender, and queer) people and issues. While at...